Navigation Links
Cancer risk among nuclear industry workers

A cohort multinational study was done involving 598 068 nuclear industry workers from 15 countries.// The study was done to estimate the risk of cancer after administrating low doses of radiation.

This study is an international collaborative study to estimate the cancer risk among radiation workers in the nuclear industry to find out the risk of cancer occurrence after low dose exposure of radiation.

The study recruits were employed in 154 different facilities, involved in nuclear power production, research, waste management and industries of fuel, isotope and weapon. During the study period, about 24,158 (5.9%) of recruits died, 6519 from cancer other than leukaemia and 196 from leukaemia (excluding lymphocytic leukaemia).

Results from the study show that there is an increased risk of cancer exists in the recruits even at a low dose and a significant increase risk for all cancers (excluding leukaemia). Some factors like smoking and diet in recruits can have an association between radiation dose and risk of cancer. Some earlier studies have found associations between radiation dose and smoking and while others have not. Factors such as smoking can confound the association between radiation doses and risk only if they are related both to risk of cancer and to dose.

Current recommendations form the International Commission on Radiological Protection (ICRP) are to limit occupational doses to 100 Sv (sieverts) over five years (not to exceed 50 Sv in any one year) and doses to the public to 1 Sv per year. This study results show that an exposure of 100 Sv will cause 9.7% mortality from cancer (excluding leukaemia), and a 5.9% increased mortality from cancers excluding leukaemia, lung, and pleura.

Our study is the largest study on nuclear industry workers conducted so far, and provides an estimation of radiation risk. These results suggest that there is an increased risk of cancer occurs even at a lower dose of nucle ar radiation.


'"/>




Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, ... a medical article to the newly revamped Cosmetic Town journal section, ... hair transplant procedure known as Follicular Unit Extraction (FUE). , Dr. ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017  Eli Lilly and Company (NYSE: ... the third quarter of 2017 on Tuesday, October 24, ... that day with the investment community and media to ... conference call will begin at 9 a.m. Eastern time. ... live webcast of the conference call through a link ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation ... and home sensors for real-time monitoring of patients with ... nonprofit organization focused on disruptive health solutions for rare ... system to record and integrate behavioral, cognitive, physiological and ... ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology: